Well-being

Wellbeing Digital Sciences Welcomes Najla Guthrie as Chief Executive Officer

Retrieved on: 
Monday, April 4, 2022
Company, Drug development, Veterans Affairs Canada, Therapy, Veteran, Interim, Post-traumatic stress disorder, Well-being, GAAP, MEDI, Association, FRA, Research, Victoria Wells Wulsin, Publication, KGK, CEO, NEO, IRP, Board of directors, Quality of life, Database, Â, GLOBE, Science, Najla, Cannabis, OTC, Patient, Publishing, SQ2, Management, Pharmaceutical industry

VANCOUVER, British Columbia, April 04, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (Wellbeing or the Company) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based healthcare company focused on innovative clinical solutions, artificial intelligence-powered digital therapeutics and contract research, and its Board of Directors are pleased to welcome Najla Guthrie as its new Chief Executive Officer (CEO) effective March 31, 2022.

Key Points: 
  • VANCOUVER, British Columbia, April 04, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (Wellbeing or the Company) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based healthcare company focused on innovative clinical solutions, artificial intelligence-powered digital therapeutics and contract research, and its Board of Directors are pleased to welcome Najla Guthrie as its new Chief Executive Officer (CEO) effective March 31, 2022.
  • Ms. Guthrie has been the President and CEO of KGK since 1997 and most recently also held the title of Chief Science Officer for Wellbeing.
  • Najla is aptly fitted for her new role as CEO of Wellbeing and is highly regarded in the research, science, and leadership communities.
  • Wellbeing Digital Sciences Inc. is an evidence-based healthcare company focused on innovative clinical solutions, artificial intelligence-powered digital therapeutics and contract research.

Going Digital to Serve Better - Social Sector Embraces Digital Technologies

Retrieved on: 
Friday, March 25, 2022
Well, Zero, Gender equality, Sustainable Development Goal 4, Organization, UN, Growth, Program, Seva, Social change, Well-being, CEO, Public employee pension plans in the United States, COVID-19, Climate change mitigation, Non-governmental organization, Volunteering, Public relations, Youth

BENGALURU, Karnataka, March 25, 2022 /PRNewswire-PRWeb/ --SociallyGood.com is driving the digital engagement for nonprofits, CSRs, individual volunteers and donors,

Key Points: 
  • Social services organizations have strongly embraced digital solutions to support post-Covid-19 related health care services and other social services.
  • SociallyGood is the social campaign promotion platform for the non-profit and social service sector.
  • SociallyGood has promoted about 3310 social campaigns enabling $18+ million donations in 2021, which is a testimony to the value digital marketplaces brings to the social service sector.
  • With more non-profits from the USA and India embracing digital tools, I am hopeful the world will be a better place with more social good from SociallyGood."

Wellbeing Digital Sciences Appoints Najla Guthrie as Chief Executive Officer

Retrieved on: 
Monday, March 7, 2022
MEDI, SQ2, Well-being, OTC, Leadership, Patient, Industry, KGK, Science, Interim, Knowledge, Cannabis, Growth, Drug development, Capital market, Communication, Company, Time, Mental health, FRA, CEO, Najla, NEO, GLOBE, Management, Pharmaceutical industry

VANCOUVER, British Columbia, March 07, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (Wellbeing or the Company) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based healthcare company focused on innovative clinical solutions, artificial intelligence-powered digital therapeutics and contract research, is pleased to announce that Najla Guthrie, the current Chief Research Officer and President of KGK Science Inc. (KGK), has been appointed as Chief Executive Officer (CEO) of Wellbeing effective March 31, 2022.

Key Points: 
  • VANCOUVER, British Columbia, March 07, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (Wellbeing or the Company) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based healthcare company focused on innovative clinical solutions, artificial intelligence-powered digital therapeutics and contract research, is pleased to announce that Najla Guthrie, the current Chief Research Officer and President of KGK Science Inc. (KGK), has been appointed as Chief Executive Officer (CEO) of Wellbeing effective March 31, 2022.
  • Najla has published over 50 articles in peer-reviewed journals and has given numerous presentations at both the national and international levels.
  • I would like to thank Adam in advance for a smooth transition at that time, said Najla Guthrie, incoming CEO of Wellbeing.
  • Wellbeing Digital Sciences Inc. (formerly KetamineOne Capital Limited) is an evidence-based healthcare company focused on innovative clinical solutions, artificial intelligence-powered digital therapeutics and contract research.

Robert Miller appointed Chief Executive Officer of Wellbeing Software

Retrieved on: 
Monday, March 7, 2022
Citadel, Data management, Marketing, Well-being, Practice management, SVP, ISOFT, HSE, Growth, Commercial Operating System (COS), NHS, MD, Health, Health information management, Software, Radiology, Management, Allscripts

LONDON, March 7, 2022 /PRNewswire/ -- Wellbeing Software , a UK market leader in connected healthcare software, is pleased to announce that Robert Miller has been appointed as Chief Executive Officer.

Key Points: 
  • LONDON, March 7, 2022 /PRNewswire/ -- Wellbeing Software , a UK market leader in connected healthcare software, is pleased to announce that Robert Miller has been appointed as Chief Executive Officer.
  • Robert has joined Wellbeing (a Citadel Group company) from Allscripts, where he was responsible for Commercial Operations across all non-US businesses.
  • Mark McConnell, Chief Executive Officer of The Citadel Group, commented:
    "I am delighted that Robert has joined Wellbeing Software as Chief Executive Officer.
  • "I am honoured to be given the opportunity to lead Wellbeing Software through the next exciting phase of its fast-paced development.

Wellbeing Digital Sciences Subsidiary IRP Health Receives Approval From Veterans Affairs Canada for Reactivation Program

Retrieved on: 
Thursday, March 3, 2022
VAC, MEDI, Well-being, Therapy, OTC, Canadian Armed Forces, Rehabilitation, Patient, Occupational therapy, Psychology, Veteran, IRP, Veterans Affairs Canada, Interim, PTSD, Drug development, Goal, Company, Pain, Mental health, FRA, NEO, Dietitian, Royal Canadian Mounted Police, Achievement, GLOBE, Pharmaceutical industry, Medicine

Reactivation is a 12-week, physician-supervised, interdisciplinary pain management program that assists veterans with chronic musculoskeletal injuries and pain.

Key Points: 
  • Reactivation is a 12-week, physician-supervised, interdisciplinary pain management program that assists veterans with chronic musculoskeletal injuries and pain.
  • The Therapy Program aims to help veterans return to behaviours that are consistent with being well, rather than behaviours that are consistent with suffering.
  • VACs approval of the Reactivation program is a significant milestone for Wellbeing and for the physical and mental health of veterans.
  • Veterans and first responders looking for more information on Reactivation and IRP locations can visit www.irphealth.ca or call +1 (778) 535-5312.

Castlight Health Announces Illuminate 2022: Workforce Health, Reimagined

Retrieved on: 
Tuesday, February 22, 2022
Linda, Well, Aetna, Castlight Health, Health, Workplace, Timeline of Richard Branson's business ventures, Elephant, Boeing, Awareness, COVID-19, Elephant in the room, Industry, Future, City, Well-being, Mental health, Fortune 500, Strategy, Health care, SAN, Attention, CVS, Society for Healthcare Strategy and Market Development, COVID, HR, MPP, MD, Management, Illuminate

SAN FRANCISCO, Feb. 22, 2022 /PRNewswire/ -- Castlight Health, Inc. announces today the details of its inaugural industry event, Illuminate: Workforce Health, Reimagined, to be held April 5, 2022, at the Portofino Hotel & Marina in Redondo Beach, California.

Key Points: 
  • SAN FRANCISCO, Feb. 22, 2022 /PRNewswire/ -- Castlight Health, Inc. announces today the details of its inaugural industry event, Illuminate: Workforce Health, Reimagined, to be held April 5, 2022, at the Portofino Hotel & Marina in Redondo Beach, California.
  • The last two years have underscored the importance of employee health through emerging trends like 'The Great Resignation', the role of mental health in the workplace, deferred care due to COVID-19, and increasing awareness of the country's glaring health inequities," said Maeve O'Meara, chief executive officer, Castlight Health.
  • "I'm excited to bring together the largest, most strategic employers with health plans and thought leaders to advance these critical conversations."
  • Castlight partners with Fortune 500 companies and health plans to transform employee and member benefits into one comprehensive health and wellbeing experience to deliver better health outcomes and maximize returns on healthcare investments.

Wellbeing Digital Sciences Delivers its First IV Ketamine Treatment Under the Inpatient KITE Program

Retrieved on: 
Tuesday, February 15, 2022
Patient, Depression, Company, Interim, Center, KITE, OTC, Well-being, Anxiety, IV, Mental health, Addition, PTSD, Ketamine, Post-traumatic stress disorder, MEDI, VW, Program, NEO, GLOBE, Drug development, Medicine, Pharmaceutical industry

Wellbeing management expects the collaboration between VW, iHealthOX and itself to experience an increase in the number of patients treated via IV ketamine infusions in the near future.

Key Points: 
  • Wellbeing management expects the collaboration between VW, iHealthOX and itself to experience an increase in the number of patients treated via IV ketamine infusions in the near future.
  • The Company and VW have launched a first-class, best practice-based, six-week inpatient Ketamine Integrated Therapy Experience ("KITE") program.
  • The first three weeks of the KITE program are structured to offer clients a unique opportunity to benefit from fast-acting and medically supervised IV ketamine administration.
  • Wellbeing Digital Sciences Inc. (formerly KetamineOne Capital Limited) is an evidence-based healthcare company focused on innovative clinical solutions, artificial intelligence-powered digital therapeutics and contract research.

Our.Love, the New Premier AI-Powered Gamified Relationship Wellness App for Couples, Set to Launch on Valentine's Day

Retrieved on: 
Wednesday, February 2, 2022
Well, Entrepreneurship, Leadership, CEO, Army of the United States, Social and Behavioral Sciences Team, Well-being, University, Emotional Freedom Techniques, Life Is Good Company, University of Virginia, Artificial intelligence, Center, Name, Meditation, Syed Talha Ahsan, Woman, Johns Hopkins School of Medicine, Machine learning, AI, IOS, Technology, Humour, Pager (company), CTO, Marketing, Hope Loves Company, Love, Company, Health, Johns Hopkins, Heartland Industrial Partners, Arnold & Porter, Science, Growth, Knowledge, Industry, Mood, Android, SkyBridge Capital, CRM, Quality of life, Research, Record, Happiness, Our Love, EFT, Shop, Management, Video game, Toy, Public relations, Financial adviser

The result of their efforts is Our.Love, a mobile app that is expected to catapult the nascent relationship technology market into the mainstream.

Key Points: 
  • The result of their efforts is Our.Love, a mobile app that is expected to catapult the nascent relationship technology market into the mainstream.
  • We are too busy and too easily distracted for the occasional book or magazine article to truly stick with us.
  • What began as a passion project for Talhas evolved into aonce-in-a-generationopportunity to launch the relationship tech industry into the mainstream.
  • The app is set in the Coupleverse, a virtual world where each couple builds a virtual relationship home as they also build their real-world relationship.

Wellbeing Digital Sciences Reveals Recent Achievements by Its KGK Science Subsidiary

Retrieved on: 
Wednesday, February 2, 2022
Growth, MEDI, Cannabis, CEO, Patient, Publication, Well-being, Clinical trial, KGK, Database, Psychedelic drug, Â, Technology, Research, Lift, COVID-19, NEO, Natural health product, Company, Interim, Health Canada, GLOBE, Acquisition, CRO, Drug development, New, Industry, Science, OTC, Safe, Pharmaceutical industry, Fine chemical

VANCOUVER, British Columbia, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (Wellbeing or the Company) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), an evidence-based healthcare company focused on innovative clinical solutions, artificial intelligence-powered digital therapeutics and contract research, is pleased to provide a corporate update highlighting the various achievements of its wholly owned subsidiary, KGK Science Inc., (KGK or the CRO).

Key Points: 
  • VANCOUVER, British Columbia, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (Wellbeing or the Company) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), an evidence-based healthcare company focused on innovative clinical solutions, artificial intelligence-powered digital therapeutics and contract research, is pleased to provide a corporate update highlighting the various achievements of its wholly owned subsidiary, KGK Science Inc., (KGK or the CRO).
  • Recapping some of 2021s highlights, KGK won contracts for 11 clinical trial service projects and 5 medical writing projects.
  • Despite the restrictions associated with the COVID-19 pandemic, KGK was able to complete the conduct of 9 clinical trials and advanced several others towards completion.
  • Wellbeing Digital Sciences Inc. (formerly KetamineOne Capital Limited) is an evidence-based healthcare company focused on innovative clinical solutions, artificial intelligence-powered digital therapeutics and contract research.

Ketamine One Changes Name to Wellbeing Digital Sciences

Retrieved on: 
Monday, January 24, 2022
Research, Patient, MEDI, News, Name change, NEO Exchange, Mental health, GLOBE, Lovecraftian horror, Well-being, OTC, Digital Science, Company, Drug development, Therapy, Frankfurt Stock Exchange, Interim, NEO, Social media, Pharmaceutical industry

Wellbeing Digital Sciences is a name that acknowledges each one of our three core pillars: clinic-based treatments, contract research and health technology, said Adam Deffett, Interim CEO of Wellbeing.

Key Points: 
  • Wellbeing Digital Sciences is a name that acknowledges each one of our three core pillars: clinic-based treatments, contract research and health technology, said Adam Deffett, Interim CEO of Wellbeing.
  • Our mission continues to be the implementation of an innovative and bespoke healthcare offering to underserved populations, such as military veterans and first responders.
  • Wellbeing Digital Sciences Inc. (formerly KetamineOne Capital Limited) is an evidence-based healthcare company focused on innovative clinical solutions, artificial intelligence-powered digital therapeutics and contract research.
  • In essence, the company exists to make breakthrough treatments more accessible and to offer patients transformational experiences.